Pomalidomide Capsules bulk supplier for pharma manufacturers

Pomalidomide Capsules 2 mg, 4 mg, 3 mg, and 4 mg Suppliers & Bulk Manufacturers

Available Forms: capsules.

Available Strengths: 2 mg, 4 mg, 3 mg, and 4 mg

Reference Brands: Talquetamide(US), Pomalyst(EU)

Pomalidomide is an immunomodulatory drug that enhances immune response and inhibits tumor growth by modulating cytokine production and stimulating T-cell activity. It effectively treats refractory multiple myeloma, improving survival, decreasing tumor burden, and supporting long-term disease control while supporting immune health.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Pomalidomide capsules, marketed as Pomalyst, are approved in the US by the FDA and in the EU via EMA for relapsed and refractory multiple myeloma. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data to ensure safety and effectiveness, while the EMA evaluates compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional requirements supports timely approval, safe use, and widespread availability, helping improve long-term outcomes for multiple myeloma patients worldwide.

Pomalidomide Capsules — third party manufacturing & bulk supply

Pomalidomide Capsules 2 mg, 4 mg, 3 mg, and 4 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Pomalidomide Capsules is supplied as capsules. — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Pomalidomide Capsules listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Pomalidomide Capsules →

Back to Listing

Frequently Asked Questions

Pomalidomide Capsules is listed as capsules. in 2 mg, 4 mg, 3 mg, and 4 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Pomalidomide Capsules is referenced against Talquetamide(US), Pomalyst(EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.